| I-16 Victor Mangas-Sanjuan Semi-mechanistic Pharmacodynamic model of complex receptor-hormone dynamics Wednesday 10:30-12:00 |
| I-36 - - Investigation of Bayesian inference in predicting tissue concentrations using RStan Wednesday 10:30-12:00 |
| I-42 Dimitrios Patsatzis Construction and evaluation of "global" Micahelis-Menten reduced models Wednesday 10:30-12:00 |
| II-02 Emilie Schindler The minimal continuous-time Markov pharmacometric model Wednesday 15:10-16:30 |
| II-04 Johannes Schropp Target-mediated drug disposition model for a bispecific antibody: development of full model and quasi-equilibrium like approximation Wednesday 15:10-16:30 |
| II-05 Pascal Schulthess Frequency-domain response analysis for quantitative systems pharmacology models Wednesday 15:10-16:30 |
| III-05 Kevin Feng Study and application of nonparametric and parametric population modeling for automatic subpopulation classification to CYP2D6 phenotype compounds and pediatric age groups Thursday 09:50-11:20 |
| III-61 Fabiola La Gamba A Bayesian PK/PD model for synergy; a case study Thursday 09:50-11:20 |
| IV-09 Geraldine Celliere Target-mediated drug-disposition (TMDD) model comparison using the MonolixSuite Thursday 14:45-16:15 |
| IV-26 Ari Brekkan Viggosson Parameter Estimation in Bivariate Mixed Hidden Markov Models Thursday 14:45-16:15 |
| IV-37 Kaelig Chatel Tobramycin dose individualization using the MonolixSuite Thursday 14:45-16:15 |
| IV-38 Jonathan Chauvin Longitudinal Model-Based Meta-Analysis (MBMA) for rheumatoid arthritis with Monolix Thursday 14:45-16:15 |
| IV-46 Shafi Chowdhury Using “Big” NONMEM Dataset Generated from Standard SDTM to Review Data and Accelerate Model Building Process Thursday 14:45-16:15 |
| IV-66 Mike Dunlavey Use of distributed delay in PML Thursday 14:45-16:15 |
